Pirespa pirfenidone regulatory update

FDA accepted for filing and granted Priority Review to an NDA from InterMune for pirfenidone to treat idiopathic pulmonary fibrosis (IPF). The PDUFA date is May 4. The oral p38 mitogen-activated prot...